CAMBRIDGE MOLECULAR DIAGNOSTICS LTD
Company number 09600771 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£3,394,341
Balance sheet as at 2024-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2015-05-20
- Employees
- 6 (2024 accounts · was 8 in 2024)
- Registered office
- 25 Science Park, Bio-Innovation Centre, Milton Road, Cambridge, England, CB4 0FW
- Postcode
- CB4 0FW
- Capital
- 6 GBP
- Accounts category
- Total Exemption Full
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-02-17
- Next due by
- 2027-03-03
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current · 7 resigned
Group structure
Controlled by Cotterford Company Limited (001906V) — since 2026-05-01
From persons-with-significant-control filings on the public register.
Data protection registration
Registered with the ICO as a data protection fee payer — ZA801148 (Tier 1), registered since 2020.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Previous registered addresses 4
| Address | Changed on |
|---|---|
| DEPARTMENT OF GENETICS DOWNING STREET, CAMBRIDGE, CB2 3EH, ENGLAND | 2020-09-25 |
| 54 NATAL ROAD, CAMBRIDGE, CB1 3NY, ENGLAND | 2016-09-28 |
| MILL HOUSE 37 MILL LANE, STETCHWORTH, NEWMARKET, CAMBS, CB8 9TR, ENGLAND | 2015-11-25 |
| 54 NATAL ROAD, CAMBRIDGE, CB1 3NY, UNITED KINGDOM | 2015-11-18 |
Among its peers
Top 25%
by shareholders' funds, of 235 similar companies in CB
Trading since 2015.
Competitors Cambridge
This company ranks 35 among research and experimental development on biotechnology in Cambridge.
The class of 2015
39%
of the 363 companies in this sector incorporated in 2015 are still active today; 58% have since been dissolved.
A fact about the year, not a forecast for this company.